Hwai Loong Kong

Collaboration Map View Statistics Email Alert RSS Feed

Full Name

Hwai Loong Kong

Variants

Kong, H.L.
Kong, H.-L.

Main Affiliation

MEDICINE

Faculty

YONG LOO LIN SCHOOL OF MEDICINE

mdckhl@nus.edu.sg

Refined By:

Date Issued: [2000 TO 2023]

Results 1-8 of 8 (Search time: 0.004 seconds).

Refman EndNote Bibtex RefWorks Excel CSV PDF Send via email

	Issue Date	Title	Author(s)
1	2005	Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC	Graepler, F.; Verbeek, B.; Graeter, T.; Smirnow, I.; Gregor, M.; Lauer, U.M.; Kong, H.L. ; Schuppan, D.; Bauer, M.; Vonthein, R.
2	2007	Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma	Chuah, B.; Lim, R.; Boyer, M.; Ong, A.-B.; Wong, S.-W.; Kong, H.-L. ; Millward, M.; Clarke, S.; Goh, B.-C.
3	Dec-2003	Oxaliplatin/Fluorouracil/Leucovorin in Advanced Colorectal Carcinoma: An Asian Experience	Lim, E.H. ; Lim, R.S.C.; Wu, T.S.; Kong, H.L.
4	2003	Oxaliplatin/Fluorouracil/Leucovorin in Advanced Colorectal Carcinoma: An Asian Experience	Lim, E.H. ; Lim, R.S.C.; Kong, H.L. ; Wu, T.S.
5	2000	Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer	Goh, B.C. ; Lehnert, M. ; Lim, H.L.; Kong, H.L. ; Lee, S.C.; Wong, J.E.L.; Ng, A.W.K.; Chan, C.C.; Wee, J.; Chua, E.T.
6	1-Nov-2002	Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients	Lim, L.L.; Wai, C.T.; Lee, Y.M. ; Kong, H.L. ; Lim, R.; Koay, E. ; Lim, S.G.
7	2002	Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients	Lim, L.L.; Wai, C.T.; Lee, Y.M. ; Lim, S.G. ; Kong, H.L. ; Lim, R.; Koay, E.
8	2001	Simulation of the delivery of doxorubicin to hepatoma	Goh, Y.-M.F.; Wang, C.-H. ; Kong, H.L.